Related Experiment Video
Updated: Jul 11, 2026

Live Cell Imaging and 3D Analysis of Angiotensin Receptor Type 1a Trafficking in Transfected Human Embryonic Kidney Cells Using Confocal Microscopy
Published on: March 27, 2017
Transport of a fluorescent cAMP analog in teleost proximal tubules
Valeska Reichel1, Rosalinde Masereeuw, Jeroen J M W van den Heuvel
1Institute of Pharmacy and Molecular Biotechnology, INF 366, 69120 Heidelberg, Germany.
Abstract:
Previous studies have shown that killifish (Fundulus heteroclitus) renal proximal tubules express a luminal membrane transporter that is functionally and immunologically analogous to the mammalian multidrug resistance-associated protein isoform 2 (Mrp2, ABCC2). Here we used confocal microscopy to investigate in killifish tubules the transport of a fluorescent cAMP analog (fluo-cAMP), a putative substrate for Mrp2 and Mrp4 (ABCC4). Steady-state luminal accumulation of fluo-cAMP was concentrative, specific, and metabolism-dependent, but not reduced by high K+ medium or ouabain. Transport was not affected by p-aminohippurate (organic anion transporter inhibitor) or p-glycoprotein inhibitor (PSC833), but cell-to-lumen transport was reduced in a concentration-dependent manner by Mrp inhibitor MK571, leukotriene C4 (LTC4), azidothymidine (AZT), cAMP, and adefovir; the latter two compounds are Mrp4 substrates. Although MK571 and LTC4 reduced transport of the Mrp2 substrate fluorescein-methotrexate (FL-MTX), neither cAMP, adefovir, nor AZT affected FL-MTX transport. Fluo-cAMP transport was not reduced when tubules were exposed to endothelin-1, Na nitroprusside (an nitric oxide generator) or phorbol ester (PKC activator), all of which signal substantial reductions in cell-to-lumen FL-MTX transport. Fluo-cAMP transport was reduced by forskolin, and this reduction was blocked by the PKA inhibitor H-89. Finally, in membrane vesicles from Spodoptera frugiperda (Sf9) cells containing human MRP4, ATP-dependent and specific uptake of fluo-cAMP could be demonstrated. Thus, based on inhibitor specificity and regulatory signaling, cell-to-lumen transport of fluo-cAMP in killifish renal tubules is mediated by a transporter distinct from Mrp2, presumably a teleost form of Mrp4.
Insights
Killifish renal tubules transport a cAMP analog via a transporter distinct from Mrp2, likely a teleost Mrp4. This finding aids understanding of renal drug and metabolite transport in fish.
Area of Science:
- Comparative Physiology
- Molecular Transport Mechanisms
- Renal Physiology
Background:
- Killifish renal proximal tubules possess a transporter similar to mammalian multidrug resistance-associated protein 2 (Mrp2).
- This transporter is implicated in the efflux of various organic anions and xenobiotics.
- Understanding piscine renal transporters is crucial for ecotoxicology and comparative medicine.
Purpose of the Study:
- To investigate the transport mechanism of a fluorescent cAMP analog (fluo-cAMP) in killifish renal tubules.
- To determine if fluo-cAMP is transported by Mrp2 or a related transporter, such as Mrp4.
- To elucidate the regulatory pathways influencing fluo-cAMP transport.
Main Methods:
- Confocal microscopy was employed to visualize fluo-cAMP transport in killifish renal tubules.
- Inhibitor studies using specific Mrp inhibitors (MK571, LTC4), substrates (cAMP, adefovir, AZT), and signaling modulators were conducted.
- Transport assays were performed in membrane vesicles expressing human MRP4 (ABCC4).
Main Results:
- Fluo-cAMP accumulation was concentrative, specific, metabolism-dependent, and sensitive to Mrp inhibitors and Mrp4 substrates.
- Transport was unaffected by Mrp2-specific inhibitors or modulators of Mrp2 transport, but was inhibited by cAMP, adefovir, and AZT.
- Human MRP4 vesicles demonstrated ATP-dependent fluo-cAMP uptake, suggesting functional homology.
Conclusions:
- Cell-to-lumen transport of fluo-cAMP in killifish renal tubules is mediated by a transporter distinct from Mrp2.
- The data strongly suggest that this transporter is a teleost form of Mrp4 (ABCC4).
- This study identifies a novel Mrp4-mediated transport pathway in fish kidney, relevant for xenobiotic and endogenous compound handling.

